Through the transfer of various tumor-related factors, EVs promote proliferation, angiogenesis, metastasis, and drug resistance of malignant tumor cells [72,73], as shown in breast cancer cells stimulated with Her2-loaded EVs [72]. This evidence concerns the gene ERBB2 and breast carcinoma.